The TGH Cardiovascular Center’s Aorta Program is made up of a multidisciplinary team of physicians specializing in vascular surgery, cardiac surgery, anesthesiology, and interventional radiology as well as specialized cardiovascular nurses and ICU teams who work together to diagnose and treat all types of aortic diseases. Our team diagnoses and treats even the most high-risk patients, including transfers from other hospitals after failure from previous procedures. As leaders in the field, our team continually conducts research and clinical trials, including numerous device development and medical management trials, in order to provide the latest treatment options to achieve the best outcomes for our patients.
Current Aorta Related Clinical Trials
- NTAAACT – NIH funded multicenter study evaluating the effectiveness of doxycycline to prevent AAA growth in patients with small (3.5-5cm) AAA’s.
- Cook TX-2 Low Profile – New low profile TEVAR device for TAAA
For more information about Tampa General Hospital’s Cardiovascular Center Aorta Program clinical trials, or to refer a patient, call (813) 394-5554 Monday through Friday, 8:00 a.m. - 4:30 p.m. To transfer patients after business hours, call the TGH Transfer Center at 1-800-247-4472.